CAMP4 THERAPEUTICS CORPORATION

10-Year Study

CAMP.US · Healthcare · US · Common Stock

Executive Summary: CAMP4 THERAPEUTICS CORPORATION has compounded at -43.8% annually over the last 10 years, with a maximum drawdown of 86.4% and an annualized volatility of 397.3%.

1Y CAGR
+144.2%
3Y CAGR
-43.8%
5Y CAGR
-43.8%
10Y CAGR
-43.8%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
86.4%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.16
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
0.30
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
131.4%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · +17.4%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · -26.8%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
50%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
2026-39.621.4-1.81.8————————-26.8%
2025-7.92.1-18.5-55.811.9-26.812.4-6.797.438.7-8.761.317.4%
2024——————————-54.99.0-50.9%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 397.3%. The dominant macroeconomic risk driver is TLT.US, accounting for 22.5% of variance. Idiosyncratic stock-specific factors contribute 3.0%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2024-10-0110000
2024-11-014506.114685121954
2024-12-014910.630041386594
2025-01-014524.929342423174
2025-02-014619.0026289292755
2025-03-013762.935048858538
2025-04-011665.0987411768306
2025-05-011862.6528671280487
2025-06-011364.0640000689014
2025-07-011533.396027924086
2025-08-011429.9153006231718
2025-09-012822.201286643903
2025-10-013913.452307268299
2025-11-013574.78825155793
2025-12-015766.6980700341455
2026-01-013480.7149650518286
2026-02-014223.8945923437095
2026-03-014148.635891366538
2026-04-014223.8945923437095
Annual Return Matrix
YearAnnual Return
20250.17432957103928493
2026-0.26753671840518267
Total Factor Risk
3.9731741451465252
VTI.US Exposure
0.011337107584480267
VEA.US Exposure
0.021520275049726877
VWO.US Exposure
0.04245040899601347
QQQ.US Exposure
0.0029967272986445325
VTV.US Exposure
0.017540671579301743
IJR.US Exposure
0.0669612122479109
QUAL.US Exposure
0.0713679980195169
SHV.US Exposure
0.1449220603511106
TLT.US Exposure
0.22516364171291625
LQD.US Exposure
0.18878481205865086
HYG.US Exposure
0.003616593791098787
GLD.US Exposure
0.0016122540314293281
USO.US Exposure
0.007815969088932529
VNQ.US Exposure
0.05532835835583677
BTC-USD.CC Exposure
-0.0003823964287569453
CPER.US Exposure
-0.002170784676326604
VIX.INDX Exposure
0.06423086710817891
UUP.US Exposure
0.046621360311928116
TIP.US Exposure
0.000034036667391262735
Idiosyncratic Exposure
0.03024882685201551
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
397.3%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$232.1M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-0.9%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+25.1%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
37.0% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
1.00
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is CAMP4 THERAPEUTICS CORPORATION a high-risk investment?

CAMP4 THERAPEUTICS CORPORATION (CAMP.US) has an annualized volatility of 397.3% and experienced a maximum drawdown of 86.4% over the last 10 years. Its primary macro risk driver is TLT.US.

What is the 10-year return of CAMP.US?

Over the past 10 years, CAMP.US has generated a Compound Annual Growth Rate (CAGR) of -43.8%. It has had a positive return in 50% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on CAMP4 THERAPEUTICS CORPORATION

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest